Literature DB >> 24744248

Novel signaling axis in CML-initiating cells.

Cheng Cheng Zhang1.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 24744248      PMCID： PMC3990909          DOI： 10.1182/blood-2014-03-560359

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  10 in total

1.  Expression of CD25 independently predicts early treatment failure of acute myeloid leukaemia (AML).

Authors:  Jan Cerny; Hongbo Yu; Muthalagu Ramanathan; Glen D Raffel; William V Walsh; Natasha Fortier; Lindsey Shanahan; Elizabeth O'Rourke; Jayde Bednarik; Bruce Barton; Aimee Kroll-Desrosiers; Suyang Hao; Bruce Woda; Lloyd Hutchinson; Andrew M Evens; Alan G Rosmarin; Rajneesh Nath
Journal:  Br J Haematol       Date:  2012-11-01       Impact factor: 6.998

Review 2.  Transcriptional responses to polypeptide ligands: the JAK-STAT pathway.

Authors:  C Schindler; J E Darnell
Journal:  Annu Rev Biochem       Date:  1995       Impact factor: 23.643

Review 3.  Pushing the limits of targeted therapy in chronic myeloid leukaemia.

Authors:  Thomas O'Hare; Matthew S Zabriskie; Anna M Eiring; Michael W Deininger
Journal:  Nat Rev Cancer       Date:  2012-07-24       Impact factor: 60.716

4.  Selectins and their ligands are required for homing and engraftment of BCR-ABL1+ leukemic stem cells in the bone marrow niche.

Authors:  Daniela S Krause; Katherine Lazarides; Juliana B Lewis; Ulrich H von Andrian; Richard A Van Etten
Journal:  Blood       Date:  2014-01-06       Impact factor: 22.113

5.  Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity.

Authors:  Amie S Corbin; Anupriya Agarwal; Marc Loriaux; Jorge Cortes; Michael W Deininger; Brian J Druker
Journal:  J Clin Invest       Date:  2010-12-13       Impact factor: 14.808

6.  IL-6 controls leukemic multipotent progenitor cell fate and contributes to chronic myelogenous leukemia development.

Authors:  Damien Reynaud; Eric Pietras; Keegan Barry-Holson; Alain Mir; Mikhail Binnewies; Marion Jeanne; Olga Sala-Torra; Jerald P Radich; Emmanuelle Passegué
Journal:  Cancer Cell       Date:  2011-11-15       Impact factor: 31.743

Review 7.  Selective elimination of leukemia stem cells: hitting a moving target.

Authors:  Leslie A Crews; Catriona H M Jamieson
Journal:  Cancer Lett       Date:  2012-08-17       Impact factor: 8.679

8.  The IL-2/CD25 axis maintains distinct subsets of chronic myeloid leukemia-initiating cells.

Authors:  Chiharu I Kobayashi; Keiyo Takubo; Hiroshi Kobayashi; Ayako Nakamura-Ishizu; Hiroaki Honda; Keisuke Kataoka; Keiki Kumano; Hideo Akiyama; Tetsuo Sudo; Mineo Kurokawa; Toshio Suda
Journal:  Blood       Date:  2014-02-26       Impact factor: 22.113

9.  Primitive CML cell expansion relies on abnormal levels of BMPs provided by the niche and on BMPRIb overexpression.

Authors:  Bastien Laperrousaz; Sandrine Jeanpierre; Karen Sagorny; Thibault Voeltzel; Sophie Ramas; Bastien Kaniewski; Martine Ffrench; Stéphanie Salesse; Franck E Nicolini; Véronique Maguer-Satta
Journal:  Blood       Date:  2013-10-07       Impact factor: 22.113

10.  CD25 expression status improves prognostic risk classification in AML independent of established biomarkers: ECOG phase 3 trial, E1900.

Authors:  Mithat Gönen; Zhuoxin Sun; Maria E Figueroa; Jay P Patel; Omar Abdel-Wahab; Janis Racevskis; Rhett P Ketterling; Hugo Fernandez; Jacob M Rowe; Martin S Tallman; Ari Melnick; Ross L Levine; Elisabeth Paietta
Journal:  Blood       Date:  2012-08-01       Impact factor: 22.113
  10 in total
  2 in total

1.  Radiobiological characteristics of cancer stem cells from esophageal cancer cell lines.

Authors:  Jian-Lin Wang; Jing-Ping Yu; Zhi-Qiang Sun; Su-Ping Sun
Journal:  World J Gastroenterol       Date:  2014-12-28       Impact factor: 5.742

2.  IGF-IR determines the fates of BCR/ABL leukemia.

Authors:  Jingjing Xie; Xiaoli Chen; Junke Zheng; Chunling Li; Satomi Stacy; Martin Holzenberger; Xuemei Hu; Cheng Cheng Zhang
Journal:  J Hematol Oncol       Date:  2015-02-04       Impact factor: 17.388
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.